Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patientsScott M. Monfort, Maryam B. Lustberg, Xueliang Pan et al.|Breast Cancer Research and Treatment|2017Cited by 129
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorRahul Mal, Mathew Cherian, Joel David et al.|Frontiers in Oncology|2020Cited by 127
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patientsMaryam B. Lustberg, Jeffrey J. Chalmers, Priya Balasubramanian et al.|Breast Cancer Research|2014Cited by 124
The Immune Microenvironment in Hormone Receptor–Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G. Waks, Sara M. Tolaney, Daniel G. Stover et al.|Clinical Cancer Research|2019Cited by 118
PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancerYanjun Hou, Zaibo Li, Hiroaki Nitta et al.|The Breast Journal|2018Cited by 78